索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]鲍礼智 苏婷 郑兴 郭志福.肥胖抑制素与心血管疾病[J].国际心血管病杂志,2019,01:22-25.
点击复制

肥胖抑制素与心血管疾病(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2019年01期
页码:
22-25
栏目:
综述
出版日期:
2019-02-20

文章信息/Info

Title:
-
作者:
鲍礼智 苏婷 郑兴 郭志福
571231 海南,中国人民解放军75560部队(鲍礼智); 200433 上海,海军军医大学附属长海医院(苏婷,郑兴,郭志福)
Author(s):
-
关键词:
肥胖抑制素;  生长激素释放肽;  心血管疾病;  多肽
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2019.01.006
文献标识码:
-
摘要:
肥胖抑制素(obestatin)是一种新型多功能肽类激素,可调节消化系统功能、体质量变化、糖脂代谢,对心血管系统有着积极的作用,如参与血压调节,对血管内皮功能、缺血再灌注损伤心肌起保护作用等。obestatin在心血管疾病治疗方面具有应用前景。
Abstract:
-

参考文献/References


[ 1 ] Zhang JV, Ren PG, Avsian-Kretchmer O, et al. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake[J]. Science, 2005, 310(5750):996-999.
[ 2 ] Alén BO, Nieto L, Gurriarán-Rodríguez U, et al. The NMR structure of human obestatin in membrane-like environments: insights into the structure-bioactivity relationship of obestatin[J]. PLoS One, 2012, 7(10):e45434.
[ 3 ] Furnes MW, Stenstrom B, Tommeras K, et al. Feeding behavior in rats subjected to gastrectomy or gastric bypass surgery[J]. Eur Surg Res, 2008, 40(3):279-288.
[ 4 ] Chanoine JP, Wong AC, Barrios V. Obestatin, acylated and total ghrelin concentrations in the perinatal rat pancreas[J]. Horm Res, 2006, 66(2):81-88.
[ 5 ] Aydin S, Ozkan Y, Erman F, et al. Presence of obestatin in breast milk: relationship among obestatin, ghrelin, and leptin in lactating women[J]. Nutrition, 2008, 24(7/8):689-693.
[ 6 ] Grönberg M, Tsolakis AV, Magnusson L, et al. Distribution of obestatin and ghrelin in human tissues: immunoreactive cells in the gastrointestinal tract, pancreas, and mammary glands[J]. J Histochem Cytochem, 2008, 56(9):793-801.
[ 7 ] 李坚旭, 董国庆, 汪月娟, 等. 肥胖儿童血obestatin、Ghrelin与胰岛素抵抗的关系[J]. 中国妇幼保健, 2013, 28(16):2557-2559.
[ 8 ] 佘野, 葛红雨, 王筝,等. 正常妊娠各期孕妇外周血中Obestatin及Ghrelin水平的变化[J]. 中国妇幼健康研究, 2015, 26(6):1146-1147.
[ 9 ] Pan W, Tu H, Kastin AJ. Differential BBB interactions of three ingestive peptides: obestatin, ghrelin, and adiponectin[J]. Peptides, 2006, 27(4):911-916.
[10] Samson WK, White MM, Price C, et al. Obestatin acts in brain to inhibit thirst[J]. Am J Physiol Regul Integr Comp Physiol, 2007, 292(1):R637-R643.
[11] Agnew A, Calderwood D, Chevallier OP, et al. Chronic treatment with a stable obestatin analog significantly alters plasma triglyceride levels but fails to influence food intake; fluid intake; body weight; or body composition in rats[J]. Peptides, 2011, 32(4):755-762.
[12] Seim I, Walpole C, Amorim L, et al. The expanding roles of the ghrelin-gene derived peptide obestatin in health and disease[J]. Mol Cell Endocrinol, 2011, 340(1):111-117.
[13] Jackson VR, Nothacker HP, Civelli O. GPR39 receptor expression in the mouse brain[J]. Neuroreport, 2006, 17(8):813-816.
[14] Moechars D, Depoortere I, Moreaux B, et al. Altered gastrointestinal and metabolic function in the GPR39-obestatin receptor-knockout mouse[J]. Gastroenterology, 2006, 131(4):1131-1141.
[15] Zhang JV, Jahr H, Luo CW, et al. obestatin induction of early-response gene expression in gastrointestinal and adipose tissues and the mediatory role of G protein-coupled receptor, GPR39[J]. Mol Endocrinol, 2008, 22(6):1464-1475.
[16] Holst B, Egerod KL, Schild E, et al. GPR39 signaling is stimulated by zinc ions but not by obestatin[J]. Endocrinology, 2007, 148(1):13-20.
[17] Tremblay F, Perreault M, Klaman LD, et al. Normal food intake and body weight in mice lacking the G protein-coupled receptor GPR39[J]. Endocrinology, 2007, 148(2):501-506.
[18] Granata R, Settanni F, Gallo D, et al. obestatin promotes survival of pancreatic beta-cells and human islets and induces expression of genes involved in the regulation of beta-cell mass and function[J]. Diabetes, 2008, 57(4):967-979.
[19] Li ZF, Guo ZF, Yang SG, et al. Circulating ghrelin and ghrelin to obestatin ratio are low in patients with untreated mild-to-moderate hypertension[J]. Regul Pept, 2010, 165(2/3):206-209.
[20] Agnew AJ, Robinson E, McVicar CM, et al. The gastrointestinal peptide obestatin induces vascular relaxation via specific activation of endothelium-dependent NO signalling[J]. Br J Pharmacol, 2012, 166(1):327-338.
[21] Anderwald-Stadler M, Krebs M, Promintzer M, et al. Plasma obestatin is lower at fasting and not suppressed by insulin in insulin-resistant humans[J]. Am J Physiol Endocrinol Metab, 2007, 293(5):E1393-E1398.
[22] Schinzari F, Veneziani A, Mores N, et al. Vascular effects of obestatin in lean and obese subjects[J]. Diabetes, 2017, 66(5):1214-1221.
[23] Iglesias MJ, Salgado A, Pineiro R, et al. Lack of effect of the ghrelin gene-derived peptide obestatin on cardiomyocyte viability and metabolism[J]. J Endocrinol Invest, 2007, 30(6):470-476.
[24] Alloatti G, Arnoletti E, Bassino E, et al. obestatin affords cardioprotection to the ischemic-reperfused isolated rat heart and inhibits apoptosis in cultures of similarly stressed cardiomyocytes[J]. Am J Physiol Heart Circ Physiol, 2010, 299(2):H470-H481.
[25] Sazdova IV, Ilieva BM, Minkov IB, et al. Obestatin as contractile mediator of excised frog heart[J]. Cent Eur J Biol, 2009, 4(3):327-334.
[26] Zhang Q, Dong XW, Xia JY, et al. Obestatin plays beneficial role in cardiomyocyte injury induced by ischemia-reperfusion in vivo and in vitro[J]. Med Sci Monit, 2017, 23:2127-2136.
[27] Kellokoski E, Kunnari A, Jokela M, et al. Ghrelin and obestatin modulate early atherogenic processes on cells: enhancement of monocyte adhesion and oxidized low-density lipoprotein binding[J]. Metabolism, 2009, 58(11):1572-1580.
[28] Xin X, Ren AJ, Zheng X, et al. Disturbance of circulating ghrelin and obestatin in chronic heart failure patients especially in those with cachexia[J]. Peptides, 2009, 30(12):2281-2285.
[29] Shi JB, Guo ZF, Zheng X, et al. Circulating obestatin is increased in patients with cardiorenal syndrome and positively correlated with vasopressin[J]. Peptides, 2012, 38(2):377-380.
[30] Samson WK, Yosten GL, Chang JK, et al. obestatin inhibits vasopressin secretion: evidence for a physiological action in the control of fluid homeostasis[J]. J Endocrinol, 2008, 196(3):559-564.
[31] 孙晓, 张曼, 王实, 等. 急性冠状动脉综合征患者血浆脑肠肽、肥胖抑制素水平变化及意义[J]. 山东医药, 2015,55(30):20-22.
[32] 严爱芬, 陈捷. obestatin与冠状动脉粥样硬化心脏病的相关性分析[J]. 中国现代医生, 2014,52(9):138-140.
[33] Guo ZF, Zheng X, Qin YW, et al. Circulating preprandial ghrelin to obestatin ratio is increased in human obesity[J]. J Clin Endocrinol Metab, 2007, 92(5):1875-1880.
[34] Beberashvili I, Katkov A, Sinuani I, et al. Serum obestatin: a biomarker of cardiovascular and all-cause mortality in hemodialysis patients[J]. Am J Nephrol, 2018, 47(4):254-265.

备注/Memo

备注/Memo:
基金项目:国家自然科学基金(NSFC 81470517)
作者单位:571231 海南,中国人民解放军75560部队(鲍礼智); 200433 上海,海军军医大学附属长海医院(苏婷,郑兴,郭志福)
通信作者:郭志福,Email:guozhifu@126.com
更新日期/Last Update: 2019-02-25